Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Green Dot Bioplastics
company
About
Green Dot Bioplastics is a biotechnology company that makes bioplastic and bio-composite pellets.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $6.50M
- Industries
- Biotechnology,Manufacturing,Plastics and Rubber Manufacturing
- Founded date
- Jan 1, 2011
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Green Dot is a full-service bio-plastic company with a wide range of sustainable materials including wood-plastic composites, starch bio-composites, and biodegradable composites. Its mission is to improve the environment in which we live by building a more sustainable world with renewable bio-based resins and promoting their use through invention, creation, and research.It was founded in 2011 and headquartered in Emporia, Kansas.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$6.50M
Green Dot Bioplastics has raised a total of
$6.50M
in funding over 2 rounds. Their latest funding was raised on
Feb 6, 2019 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 6, 2019 | Series A | $6.50M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Green Dot Bioplastics is funded by 1 investors.
Innovation In Motion
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
